Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lasix for the Prevention of De Novo Postpartum Hypertension: A Randomized Controlled Trial (LAPP Trial)

NCT04752475 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04752475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04752475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lasix for the Prevention of De Novo Postpartum Hypertension: A Randomized Controlled Trial (LAPP Trial)
Lead sponsor
Columbia University
Phase
Phase 3
Overall status
Completed
Start date
October 20, 2021
Completion date
May 28, 2022
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypertension, pregnancy-induced, postpartum preeclampsia, postpartum pregnancy-induced hypertension